AUTL Earnings Autolus Therapeutics plc
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–18 of 18
| Q1 2026 | 2026-03-31 | -0.27 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -1.08 | 2026-03-27 | 10-K |
| Q3 2025 | 2025-09-30 | -0.74 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.44 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.26 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -0.86 | 2026-03-27 | 10-K |
| Q3 2025 | 2024-09-30 | -0.77 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.43 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.24 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -1.20 | 2025-03-20 | 10-K |
| Q3 2024 | 2023-09-30 | -0.75 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.49 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.23 | 2024-05-17 | 10-Q |
| FY 2023 | 2022-12-31 | -1.57 | 2024-03-21 | 10-K |
| FY 2023 | 2022-09-30 | -0.47 | 2024-03-21 | 10-K |
| FY 2023 | 2022-06-30 | -0.46 | 2024-03-21 | 10-K |
| FY 2023 | 2022-03-31 | -0.41 | 2024-03-21 | 10-K |
| FY 2023 | 2021-12-31 | -1.97 | 2024-03-21 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.